PR Newswire
CHICAGO, July 24, 2023
CHICAGO, July 24, 2023 /PRNewswire/ -- In the near future, the cell culture media industry is poised to undergo a significant transformation, driven by advancements in biotechnology, personalized medicine, and increased demand for cell-based therapies. With growing emphasis on precision medicine and regenerative therapies, there will be a surge in the development of innovative cell culture media formulations tailored to specific cell types and applications. These cutting-edge media will be optimized to support the growth and functionality of various cells, including stem cells, primary cells, and specialized cell lines. Moreover, the integration of artificial intelligence and machine learning into media development processes will enable rapid optimization and customization, resulting in highly efficient and cost-effective solutions. As the industry continues to evolve, collaborations between academia, research institutions, and biotechnology companies will play a pivotal role in accelerating advancements and ultimately revolutionizing the landscape of cell culture media, paving the way for groundbreaking discoveries and transformative medical treatments.
Cell Culture Media Market in terms of revenue was estimated to be worth $6.2 Billion in 2023 and is poised to reach $13.0 Billion by 2028, growing at a CAGR of 16.0% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of the market is majorly attributable to increased demand for biosimilars and mAbs globally, rising investment & funding for stem cell research, focus of key market players on launch of novel products in the market.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97468536
Browse in-depth TOC on "Cell Culture Media Market"
314 - Tables
41 - Figures
291 - Pages
Cell Culture Media Market Scope:
Report Coverage | Details |
Market Revenue in 2023 | $6.2 Billion |
Estimated Value by 2028 | $13.0 Billion |
Growth Rate | Poised to grow at a CAGR of 16.0% |
Market Size Available for | 2021–2028 |
Forecast Period | 2023–2028 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Application, End user and Region |
Geographies Covered | North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA) |
Report Highlights | Updated financial information / product portfolio of players |
Key Market Opportunities | Increasing incidence of infectious diseases and outbreaks of pandemics |
Key Market Drivers | Increasing demand for serum and animal component-free media |
In 2022, the serum-free media segment accounted for the largest share of the type segment in the cell culture media market.
On the basis of type, the cell culture media market is divided into serum-free media, classical media & salts, stem cell culture media, specialty media, chemically defined media, and other cell culture media. In 2022, the serum-free media segment holds for the bigest share of the market. Factors responsible for the growth of this segment includes various advantages or benefits of serum-free media over other types of cell culture media.
In 2022, the biopharmaceutical production segment accounted for the largest share of the application segment in the cell culture media market.
On the basis of application, the cell culture media market is categorized into biopharmaceutical production, diagnostics, drug discovery & development, tissue engineering & regenerative medicine, and other applications. The biopharmaceutical production segment is estimated to grow at the highest growth rate during the forecast period. Factors responsible for the growth include, the growing production of cell culture-based vaccines, and expansion of pharmaceutical industry. The biopharmaceutical production applications of cell culture media include the manufacturing of biologic-based products such as vaccines, monoclonal antibodies, and other therapeutic proteins (such as anticoagulants, enzymes, blood factors, hormones, interferons, growth factors, interleukins, engineered proteins, and thrombolytics, among others).
In 2022, the Asia Pacific region is the fastest-growing region of the cell culture media market.
On the basis of the region, the global cell culture media market has been segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. During the forecast period, the Asia Pacific market is estimated to register the highest CAGR during the forecast period. Increased focus of key market players on geographical expansion in emerging markets, favorable government policies and support for cell-based vaccines in the region and less manufacturing cost are some of the major factors anticipated to have positive impact on the market growth of Asia Pacific region.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=97468536
Cell Culture Media Market Dynamics:
Drivers:
Restraints:
Opportunities:
Challenges:
Key Market Players:
Key players in the cell culture media market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson and Company (US), Miltenyi Biotec (Germany), and among others.
Recent Developments:
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=97468536
Cell Culture Media Market Advantages:
Overall, the cell culture media market's advantages have revolutionized modern biomedical research, playing a pivotal role in advancing scientific knowledge, drug development, and regenerative medicine, while contributing to the growth of the biotechnology and pharmaceutical industries.
Related Reports:
Cell Culture Market - Global Forecasts to 2028
Cell-based Assays Market - Global Forecasts to 2028
Sterile Filtration Market - Global Forecasts to 2028
Stem Cell Manufacturing Market - Global Forecasts to 2026
Cell Expansion Market - Global Forecasts to 2025
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-culture-media-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/cell-culture-media.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/cell-culture-media-market-worth-13-0-billion--marketsandmarkets-301883801.html